At Breethwell, we are dedicated to innovating
respiratory health for a better tomorrow.
Our pioneering CMAP technology (Continuously Monitoring Airway Pressure) is revolutionizing how we understand and manage respiratory conditions. By tackling critical issues such as Day Apnea™, Wake Apnea™, Screen Apnea™, and Email Apnea™, we are opening doors to new research, therapeutic applications, and enhanced wellness opportunities.
Breathe Better. Live Better.
At Breethwell, we believe your breath holds the key to better health, sharper focus, and longer life, and we’re on a mission to help you reclaim it.
Born from over 20 years of clinical and behavioral research, our breakthrough device, CMAP (Continuously Monitoring Airway Pressure), is redefining how we understand and manage Day Apnea®, Screen Apnea®, and the modern epidemic of dysfunctional breathing.
Whether you're a wellness seeker, healthcare innovator, or forward-thinking investor, now is the time to join a movement that’s poised to change lives and possibly save them.
Coming Soon: CMAP Launching Q1 2026
We’re working hard to bring CMAP to market by early 2026, and every breath we take is one step closer to:
Helping users monitor and correct irregular daytime breathing
Providing real-time feedback and guided breathing support
Supporting wellness, performance, and long-term prevention of hypertension, fatigue, and anxiety
Let’s breathe better. Together.
Because when you change your breath,
you change everything.
Technology
Smart Solutions for Better Breathing
Our innovative wearable IoT device continuously monitors airway pressure, offering unparalleled insights into your breathing patterns. It connects seamlessly with our app for in-depth analytics and personalized recommendations.
Experience the next generation of respiratory care with Breethwell's nasal and tongue hygiene items that complement our wearable device. Receive a free ebook packed with valuable insights upon signing up.